Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
EVO vs LSCC
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
EVO vs LSCC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Semiconductors |
| Market Cap | $1.08B | $16.43B |
| Revenue (TTM) | $786M | $574M |
| Net Income (TTM) | $-104M | $20M |
| Gross Margin | 14.4% | 66.9% |
| Operating Margin | -8.7% | 5.5% |
| Forward P/E | — | 114.2x |
| Total Debt | $447M | $78M |
| Cash & Equiv. | $418M | $134M |
EVO vs LSCC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Evotec SE (EVO) | 100 | 22.6 | -77.4% |
| Lattice Semiconduct… (LSCC) | 100 | 482.2 | +382.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EVO vs LSCC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EVO is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 0 yrs, beta 1.08
- Rev growth -5.0%, EPS growth 50.0%, 3Y rev CAGR 0.3%
- Lower volatility, beta 1.08, Low D/E 55.0%, current ratio 2.07x
LSCC carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 22.1% 10Y total return vs EVO's 132.9%
- 2.7% revenue growth vs EVO's -5.0%
- 3.5% margin vs EVO's -13.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.7% revenue growth vs EVO's -5.0% | |
| Quality / Margins | 3.5% margin vs EVO's -13.2% | |
| Stability / Safety | Beta 1.08 vs LSCC's 2.48 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +146.9% vs EVO's -26.9% | |
| Efficiency (ROA) | 2.3% ROA vs EVO's -5.3%, ROIC 1.8% vs -10.5% |
EVO vs LSCC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EVO vs LSCC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LSCC leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EVO and LSCC operate at a comparable scale, with $786M and $574M in trailing revenue. LSCC is the more profitable business, keeping 3.5% of every revenue dollar as net income compared to EVO's -13.2%. On growth, LSCC holds the edge at +42.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $786M | $574M |
| EBITDAEarnings before interest/tax | -$36M | $63M |
| Net IncomeAfter-tax profit | -$104M | $20M |
| Free Cash FlowCash after capex | -$92M | $152M |
| Gross MarginGross profit ÷ Revenue | +14.4% | +66.9% |
| Operating MarginEBIT ÷ Revenue | -8.7% | +5.5% |
| Net MarginNet income ÷ Revenue | -13.2% | +3.5% |
| FCF MarginFCF ÷ Revenue | -11.7% | +26.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.4% | +42.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +137.1% | +3.4% |
Valuation Metrics
EVO leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.1B | $16.4B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $16.4B |
| Trailing P/EPrice ÷ TTM EPS | -9.27x | 5377.58x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 114.18x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 284.32x |
| Price / SalesMarket cap ÷ Revenue | 1.22x | 31.40x |
| Price / BookPrice ÷ Book value/share | 1.13x | 23.22x |
| Price / FCFMarket cap ÷ FCF | — | 123.92x |
Profitability & Efficiency
LSCC leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
LSCC delivers a 2.8% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-12 for EVO. LSCC carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to EVO's 0.55x. On the Piotroski fundamental quality scale (0–9), LSCC scores 5/9 vs EVO's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -11.5% | +2.8% |
| ROA (TTM)Return on assets | -5.3% | +2.3% |
| ROICReturn on invested capital | -10.5% | +1.8% |
| ROCEReturn on capital employed | -9.1% | +2.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.55x | 0.11x |
| Net DebtTotal debt minus cash | $29M | -$56M |
| Cash & Equiv.Liquid assets | $418M | $134M |
| Total DebtShort + long-term debt | $447M | $78M |
| Interest CoverageEBIT ÷ Interest expense | -5.81x | 6.02x |
Total Returns (Dividends Reinvested)
LSCC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LSCC five years ago would be worth $23,723 today (with dividends reinvested), compared to $1,501 for EVO. Over the past 12 months, LSCC leads with a +146.9% total return vs EVO's -26.9%. The 3-year compound annual growth rate (CAGR) favors LSCC at 12.3% vs EVO's -30.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -4.1% | +52.5% |
| 1-Year ReturnPast 12 months | -26.9% | +146.9% |
| 3-Year ReturnCumulative with dividends | -65.9% | +41.8% |
| 5-Year ReturnCumulative with dividends | -85.0% | +137.2% |
| 10-Year ReturnCumulative with dividends | +132.9% | +2210.6% |
| CAGR (3Y)Annualised 3-year return | -30.2% | +12.3% |
Risk & Volatility
Evenly matched — EVO and LSCC each lead in 1 of 2 comparable metrics.
Risk & Volatility
EVO is the less volatile stock with a 1.08 beta — it tends to amplify market swings less than LSCC's 2.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LSCC currently trades 93.7% from its 52-week high vs EVO's 63.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.08x | 2.48x |
| 52-Week HighHighest price in past year | $4.80 | $127.95 |
| 52-Week LowLowest price in past year | $2.31 | $43.90 |
| % of 52W HighCurrent price vs 52-week peak | +63.5% | +93.7% |
| RSI (14)Momentum oscillator 0–100 | 61.3 | 64.5 |
| Avg Volume (50D)Average daily shares traded | 120K | 1.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates EVO as "Buy" and LSCC as "Buy". Consensus price targets imply 129.5% upside for EVO (target: $7) vs -11.0% for LSCC (target: $107).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $7.00 | $106.70 |
| # AnalystsCovering analysts | 7 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.6% |
LSCC leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EVO leads in 1 (Valuation Metrics). 1 tied.
EVO vs LSCC: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is EVO or LSCC a better buy right now?
For growth investors, Lattice Semiconductor Corporation (LSCC) is the stronger pick with 2.
7% revenue growth year-over-year, versus -5. 0% for Evotec SE (EVO). Lattice Semiconductor Corporation (LSCC) offers the better valuation at 5377. 6x trailing P/E (114. 2x forward), making it the more compelling value choice. Analysts rate Evotec SE (EVO) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — EVO or LSCC?
Over the past 5 years, Lattice Semiconductor Corporation (LSCC) delivered a total return of +137.
2%, compared to -85. 0% for Evotec SE (EVO). Over 10 years, the gap is even starker: LSCC returned +22. 1% versus EVO's +132. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — EVO or LSCC?
By beta (market sensitivity over 5 years), Evotec SE (EVO) is the lower-risk stock at 1.
08β versus Lattice Semiconductor Corporation's 2. 48β — meaning LSCC is approximately 129% more volatile than EVO relative to the S&P 500. On balance sheet safety, Lattice Semiconductor Corporation (LSCC) carries a lower debt/equity ratio of 11% versus 55% for Evotec SE — giving it more financial flexibility in a downturn.
04Which is growing faster — EVO or LSCC?
By revenue growth (latest reported year), Lattice Semiconductor Corporation (LSCC) is pulling ahead at 2.
7% versus -5. 0% for Evotec SE (EVO). On earnings-per-share growth, the picture is similar: Evotec SE grew EPS 50. 0% year-over-year, compared to -94. 9% for Lattice Semiconductor Corporation. Over a 3-year CAGR, EVO leads at 0. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — EVO or LSCC?
Lattice Semiconductor Corporation (LSCC) is the more profitable company, earning 0.
6% net margin versus -13. 1% for Evotec SE — meaning it keeps 0. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LSCC leads at 2. 9% versus -17. 9% for EVO. At the gross margin level — before operating expenses — LSCC leads at 68. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is EVO or LSCC more undervalued right now?
Analyst consensus price targets imply the most upside for EVO: 129.
5% to $7. 00.
07Which pays a better dividend — EVO or LSCC?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is EVO or LSCC better for a retirement portfolio?
For long-horizon retirement investors, Evotec SE (EVO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
08), +132. 9% 10Y return). Lattice Semiconductor Corporation (LSCC) carries a higher beta of 2. 48 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EVO: +132. 9%, LSCC: +22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between EVO and LSCC?
These companies operate in different sectors (EVO (Healthcare) and LSCC (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.